Squarepoint’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-81
Closed -$6K 2756
2019
Q4
$6K Sell
81
-4
-5% -$280 ﹤0.01% 2438
2019
Q3
$5K Sell
85
-11
-11% -$717 ﹤0.01% 2286
2019
Q2
$5K Buy
+96
New +$16.7K ﹤0.01% 2324
2018
Q3
Sell
-54
Closed -$46K 2304
2018
Q2
$46K Buy
+54
New +$44.8K ﹤0.01% 1693
2015
Q2
Sell
-61
Closed -$87K 647
2015
Q1
$87K Buy
+61
New +$77.4K 0.03% 402

Other funds holding HSTO

Squarepoint's HSTO Position: Q1 2020 in Review

Squarepoint sold out of Histogen Inc. Common Stock (HSTO) in Q1 2020, closing a stake of 81 shares — an estimated $6K sold.

Squarepoint first reported a position in HSTO in Q1 2015 and held it in 5 quarters. The position peaked at $87K in Q1 2015. 27 funds tracked by Wall St. Rank hold HSTO as of Q1 2020.

  • Squarepoint reported no remaining Histogen Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Squarepoint sold 81 Histogen Inc. Common Stock shares in Q1 2020, an estimated $6K.
  • Squarepoint first reported a position in Histogen Inc. Common Stock in Q1 2015 and held it in 5 quarters.
  • Squarepoint's Histogen Inc. Common Stock position peaked at $87K in Q1 2015.
  • 27 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2020.

Based on Squarepoint's 13F filing for Q1 2020, filed 15 May 2020.